Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 157

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 157
---
, individuals who were previously employed at universities or biometric solution, genetic testing, diagnostic or other healthcare companies, including our competitors or potential competitors. Although we try to ensure that our employees and consultants do not use the proprietary information or know -howof others in their work for us, we may be subject to claims that we or our employees or consultants have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information, of a former employer or other third parties. Further, we may be subject to ownership disputes in the future arising, for example, from conflicting obligations of consultants or others who are involved in developing our intellectual property. Litigation may be necessary to defend against such claims. If we fail in defending against any such claims, we could be subject to monetary damages and the loss of valuable intellectual property rights or personnel. Even if we are successful in defending against any such claim, litigation could result in substantial costs, distract management and other employees and damage our reputation. Risks Related to Operating in Argentina The Business Combination is subject to antitrust regulation in Argentina. The Business Combination is subject to review under Argentine antitrust and competition laws, including Law No. 27,442 ( Ley de Defensa de la Competencia). We will be required, within seven days of the Closing, to file notice of the Closing with applicable antitrust authorities in Argentina (however, regulatory changes may take place in the near future that may require notification prior to the Closing), and to provide upon request any additional information required by such authorities. There can be no guarantee that the Business Combination will be approved by the applicable antitrust authorities in Argentina, and, if successful, final approval of the Business Combination may take an extended period of time to secure. If the Business Combination is not approved, we may be required to unwind the transactions comprising the Business Combination. Even if the Business Combination is approved, the applicable antitrust authorities in Argentina may, as a condition to their approval of the Business Combination, impose requirements or limitations or require divestitures or place restrictions on the conduct of our business after the closing. These requirements, limitations, divestitures or restrictions could reduce the anticipated benefits of the Business Combination. Any of the foregoing consequences could have a material adverse effect on our business, financial condition, results of operations or growth prospects. Argentina has experienced, and may continue to experience, adverse economic or political conditions, including considerable economic uncertainty that may impact our business, financial condition and results of operations. A major portion of our operations and/or development activities are based